Blood Test Can Reliably Predict Patient Risk of Long COVID
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
Already a member? Log in here
Qiagen Enters Neurology Space with Parkinson’s CDx Collaboration
The developer of NGS-based companion diagnostics targets the growing neurology biomarker market.
Blood-Based Alzheimer’s Tests Are Here, but Not Ready for Widespread Use
While new FDA clearances of blood-based early detection tests for Alzheimer’s represent significant progress, limitations remain.
Already a member? Log in here
Rebounds in Core Lab Services Offset Declines in COVID-19 Test Revenues
Second quarter diagnostics earnings were down, but not as much as predicted.
Amazon Ends Telehealth Services, but Forges Ahead with Healthcare Disruption
In a surprise move, the e-retail giant announced it will close down its Amazon Care Primary Health Services for employees at the end of 2022.
Already a member? Log in here